Reduced cardiovascular morbidity in patients with hemophilia: results of a 5-year multinational prospective study

Hemophilia is a congenital bleeding disorder caused by low levels of clotting factor VIII or IX. The life expectancy of people with hemophilia (PWH) has increased with the availability of clotting factor concentrates. At the same time, the incidence of cardiovascular disease (CVD) has increased; in...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Der Valk, Paul, Makris, Michael, Fischer, Kathelijn, Tait, Robert C., Chowdary, Pratima, Collins, Peter W., Meijer, Karina, van Vulpen, Lize F. D., Mauser-Bunschoten, Eveline, Schutgens, Roger E. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945305/
https://www.ncbi.nlm.nih.gov/pubmed/34879394
http://dx.doi.org/10.1182/bloodadvances.2021005260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945305/
https://www.ncbi.nlm.nih.gov/pubmed/34879394
http://dx.doi.org/10.1182/bloodadvances.2021005260

Ejemplares similares